Simponi (golimumab) is a biologic medicine that helps treat the pain and swelling of arthritis.
Simponi belongs to a class of similar medications called Anti-Tumor Necrosis Factor (Anti-TNF) agents. These medications work by blocking Tumor Necrosis Factor (TNF), a type of signalling protein called a cytokine that is involved in systemic inflammation.
Simponi may be prescribed in combination with other medications like methotrexate.
Simponi is available as a monthly subcutaneous (under the skin) injection called Simponi SC, and an IV infusion called Simponi IV.
Simponi can take about 2 weeks before patients start to feel its effects. Some patients notice a benefit shortly after their first dose, while in others it can take several weeks. It can take 4 to 12 weeks before patients feel a lot of benefit.
The manufacturer of Simponi offers a support program to Canadian patients that are prescribed the medication:Patient support program enrolment forms
Important Tests and Risks
Watch Canadian rheumatologist Dr. Andy Thompson introduce Simponi in this short video:
Drug Identification Number (DIN)